[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@dg_fit61882 Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::1888599248654233600.png) @dg_fit61882 PaganoCapital

PaganoCapital posts on X about $pasg, $ixhl, stocks, $abvx the most. They currently have XX followers and XX posts still getting attention that total XXXXX engagements in the last XX hours.

### Engagements: XXXXX [#](/creator/twitter::1888599248654233600/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1888599248654233600/c:line/m:interactions.svg)

- X Week XXXXX +108%
- X Month XXXXXX +368%

### Mentions: XX [#](/creator/twitter::1888599248654233600/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1888599248654233600/c:line/m:posts_active.svg)

- X Week XX +7.10%
- X Month XX +173%

### Followers: XX [#](/creator/twitter::1888599248654233600/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1888599248654233600/c:line/m:followers.svg)

- X Week XX +37%
- X Month XX +344%

### CreatorRank: XXXXXXX [#](/creator/twitter::1888599248654233600/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1888599248654233600/c:line/m:influencer_rank.svg)

### Social Influence [#](/creator/twitter::1888599248654233600/influence)
---

**Social category influence**
[finance](/list/finance)  XXXXX% [cryptocurrencies](/list/cryptocurrencies)  XXXXX% [stocks](/list/stocks)  XXXXX% [countries](/list/countries)  XXXX% [currencies](/list/currencies)  XXXX% [technology brands](/list/technology-brands)  XXXX%

**Social topic influence**
[$pasg](/topic/$pasg) 15.22%, [$ixhl](/topic/$ixhl) #9, [stocks](/topic/stocks) 6.52%, [$abvx](/topic/$abvx) #6, [$250m](/topic/$250m) 4.35%, [market cap](/topic/market-cap) 4.35%, [$drug](/topic/$drug) 4.35%, [eps](/topic/eps) 4.35%, [$cmg](/topic/$cmg) 4.35%, [$srpt](/topic/$srpt) XXXX%

**Top accounts mentioned or mentioned by**
[@etheltrades11](/creator/undefined) [@marcusredpilius](/creator/undefined) [@peloswing](/creator/undefined) [@stockrocket1](/creator/undefined)

**Top assets mentioned**
[Passage (PASG)](/topic/$pasg) [Chipotle Mexican Grill, Inc. (CMG)](/topic/$cmg) [Sarepta Therapeutics, Inc. (SRPT)](/topic/$srpt) [CRISPR Therapeutics AG (CRSP)](/topic/$crsp) [Acadia Pharmaceuticals Inc. (ACAD)](/topic/$acad) [ResMed Inc. (RMD)](/topic/$rmd) [Elevance Health Inc (ELV)](/topic/$elv) [Royalty Pharma plc Class A Ordinary Shares (RPRX)](/topic/$rprx) [Muhdo Hub (DNA)](/topic/$dna) [Lucid Group Inc (LCID)](/topic/$lcid) [Doge Jones Industrial Average (DJI)](/topic/$dji) [SPX6900 (SPX)](/topic/$spx) [Hundred Million (100M)](/topic/$100m) [Iconic (ICON)](/topic/$icon) [Vertex Protocol (VRTX)](/topic/$vrtx) [Biogen Inc (BIIB)](/topic/$biib) [Regeneron Pharmaceuticals Inc (REGN)](/topic/$regn) [Eli Lilly and Company (LLY)](/topic/$lly) [BEAM (BEAM)](/topic/$beam) [Cellula (CELA)](/topic/$cela) [Novavax Inc (NVAX)](/topic/$nvax)
### Top Social Posts [#](/creator/twitter::1888599248654233600/posts)
---
Top posts by engagements in the last XX hours

"I've got 1/2 position going into this. Will add more over $X with good data"  
![@dg_fit61882 Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::1888599248654233600.png) [@dg_fit61882](/creator/x/dg_fit61882) on [X](/post/tweet/1948383353927008663) 2025-07-24 14:02:45 UTC XX followers, XXX engagements


"$RMD chatter picking up rumors of a partnership or even buyout of $IXHL are circulating. It might not be just smoke. Dr. Alison Wimms a ResMed rep officially sits on IXHLs clinical advisory board for their sleep apnea program. Thats not speculation thats real. If IXHLs non-CPAP pill works it could disrupt RMDs core market. Getting in early could be strategic. But its still early-stage. No deals been announced and IXHLs data is still pending. Could be positioning. Could be just pumpers. Either way watching closely $IXHL $RMD #biotech #sleepapnea"  
![@dg_fit61882 Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::1888599248654233600.png) [@dg_fit61882](/creator/x/dg_fit61882) on [X](/post/tweet/1949209373722763421) 2025-07-26 20:45:03 UTC XX followers, XXX engagements


"$LRMR will report OLE data in Sept for nomlabofusp in Friedreichs Ataxia. Key: confirm skin FXN as surrogate for BLA in Q2 2026. Prior Ph2 showed 3.54.2x increase in FXN vs baseline. If OLE data confirms path to approval shortens. $157M cash. Single-asset risk remains"  
![@dg_fit61882 Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::1888599248654233600.png) [@dg_fit61882](/creator/x/dg_fit61882) on [X](/post/tweet/1944504592668238004) 2025-07-13 21:09:56 UTC XX followers, XXX engagements


"7/12 Cash runway ✔ They ended Q1 2025 with $12.7M and raised another $5M in April. That covers pre-launch operations into early 2026 based on recent filings. No debt. Low burn. Theyre lean and laser-focused on launch"  
![@dg_fit61882 Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::1888599248654233600.png) [@dg_fit61882](/creator/x/dg_fit61882) on [X](/post/tweet/1948104188657058158) 2025-07-23 19:33:27 UTC XX followers, XX engagements


"Bright Minds Biosciences $DRUG trades at $XXXXX giving it a market cap of $250M with just 7.08M shares outstanding (7375% institutional ownership) . Its lead molecule BMB101 is now in an open-label Phase X trial for absence epilepsy & DEE after XXX% seizure survival in SUDEP mouse models . TD Cowen and Chardan initiated Buy coverage with price targets in the $80$92 range . Highly selective 5HT2C agonist designed to minimize tolerance via Gq pathway activation. Phase X depends on upcoming data. #Biotech #Epilepsy #CNS #Microcap"  
![@dg_fit61882 Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::1888599248654233600.png) [@dg_fit61882](/creator/x/dg_fit61882) on [X](/post/tweet/1949196238639026450) 2025-07-26 19:52:52 UTC XX followers, XX engagements


"🚨 $CMG New position opened after earnings: CMG 10/17 XXXX C @ XXXX avg ✳ Q2 2025 Earnings Recap 🔹 Revenue: $3.06B (+3% YoY) 🔹 Same-store sales: X% (first decline since 2020) 🔹 EPS: $XXXX (in line) 🔹 Net income: $436M 🔹 Digital sales: XXXX% of total 🔹 Buybacks: $435.9M repurchased ($50/share); $838.8M still authorized ✳ Valuation (as of July XX 2025) 🔹 Market Cap: $62.7B 🔹 EV/EBITDA: XXXX 🔹 P/E (TTM): XX down XX% from 12mo avg (50) 🔹 Forward P/E: XX ✳ Outlook 🔹 FY25 guide: flat comp sales (cut from low-single digit growth) 🔹 Plan to open 315345 new units (80% with Chipotlanes) 🔹"  
![@dg_fit61882 Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::1888599248654233600.png) [@dg_fit61882](/creator/x/dg_fit61882) on [X](/post/tweet/1949223867421184345) 2025-07-26 21:42:39 UTC XX followers, XX engagements


"11/12 There are very few FDA-approved late-stage biotech companies trading under 30m mkt cap with a real product a near-term launch a commercial partner and a billion-dollar TAM. ITRM fits that profile. Most people are simply not paying attention"  
![@dg_fit61882 Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::1888599248654233600.png) [@dg_fit61882](/creator/x/dg_fit61882) on [X](/post/tweet/1948104196244554178) 2025-07-23 19:33:29 UTC XX followers, XXX engagements


"$PASG up XX% over that $X i was looking for. Took full position. See previous tweets"  
![@dg_fit61882 Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::1888599248654233600.png) [@dg_fit61882](/creator/x/dg_fit61882) on [X](/post/tweet/1948739205947162738) 2025-07-25 13:36:47 UTC XX followers, XXX engagements


"Just took a position in $ELV. Q2 revs grew XX% to $49.4B with 45M+ members. Yes MCR rose to XXXX% and FY EPS was cutbut this is a blue-chip healthcare giant trading at a discount. Long-term care buybacks and cash flow make this a value+growth play"  
![@dg_fit61882 Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::1888599248654233600.png) [@dg_fit61882](/creator/x/dg_fit61882) on [X](/post/tweet/1947296316691722402) 2025-07-21 14:03:15 UTC XX followers, XX engagements


"10/12 Global IP protection is in place. Iterum received a patent in Australia extending coverage through 2039 and more are expected globally. This isnt a 2-year opportunity this could be a decade-long cashflow story"  
![@dg_fit61882 Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::1888599248654233600.png) [@dg_fit61882](/creator/x/dg_fit61882) on [X](/post/tweet/1948104194696839208) 2025-07-23 19:33:28 UTC XX followers, XX engagements


"The biotech space is on fire. Which of these are you watching $SRPT $IXHL $ABVX $RPRX $CRSP $DNA Safety drama breakout charts big trials and buy signals Which ones on your radar and why Drop your take 👇 #Biotech #Stocks #Momentum"  
![@dg_fit61882 Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::1888599248654233600.png) [@dg_fit61882](/creator/x/dg_fit61882) on [X](/post/tweet/1949118174043275353) 2025-07-26 14:42:40 UTC XX followers, XXX engagements


"8/12 Only XX million shares outstanding. No reverse split since FDA approval. No ATM abuse. The float is tiny. That means when volume comes in especially near launch this can move fast. Im positioned before that"  
![@dg_fit61882 Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::1888599248654233600.png) [@dg_fit61882](/creator/x/dg_fit61882) on [X](/post/tweet/1948104190435504242) 2025-07-23 19:33:27 UTC XX followers, XX engagements


"4/12 UTIs are extremely common. About XX million prescriptions are written each year in the U.S. Around 2530% involve resistant bacteria. And only two oral drugs have been FDA-approved for uUTIs in the last XX years. ORLYNVAH is #3. And its different"  
![@dg_fit61882 Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::1888599248654233600.png) [@dg_fit61882](/creator/x/dg_fit61882) on [X](/post/tweet/1948104183078617405) 2025-07-23 19:33:25 UTC XX followers, XX engagements


"$PASG resistance @ XXX XXX XXXX XXX. Data soon"  
![@dg_fit61882 Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::1888599248654233600.png) [@dg_fit61882](/creator/x/dg_fit61882) on [X](/post/tweet/1948763758400291204) 2025-07-25 15:14:20 UTC XX followers, XX engagements


"$PASG just saw insider buying from XX% holder Lynx1 Capital128848 shares scooped in the $5.40$5.70 range ($720K). This lines up perfectly with the potential double bottom setup near $XXXX. Big money stepping in right where the chart needed it 👀 data soon"  
![@dg_fit61882 Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::1888599248654233600.png) [@dg_fit61882](/creator/x/dg_fit61882) on [X](/post/tweet/1948565051939705301) 2025-07-25 02:04:45 UTC XX followers, XXX engagements


"$PASG Double Bottom If we pop with some volume ill take a position. Last reported cash 63mil. Market cap 16mil. Couple of catalysts this year. Anyone watching"  
![@dg_fit61882 Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::1888599248654233600.png) [@dg_fit61882](/creator/x/dg_fit61882) on [X](/post/tweet/1947492145579102671) 2025-07-22 03:01:24 UTC XX followers, XXX engagements


"@PeloSwing $LCID finally showing some life after months of tight range compression. This kind of move off the lows can catch shorts offside. Lets see if it can hold over $3"  
![@dg_fit61882 Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::1888599248654233600.png) [@dg_fit61882](/creator/x/dg_fit61882) on [X](/post/tweet/1949171889194078711) 2025-07-26 18:16:06 UTC XX followers, XXX engagements


"🚨 Big news: U.S. and EU strike a landmark trade deal U.S. to impose a XX% tariff on most EU goods in exchange for $XXX B in investments and $XXX B in energy & defense purchases from Europe Markets are rallying: all-time highs across $SPX $DJI $NDX and European equities like $SX5E (Euro Stoxx50) are gaining reducing downside risk and providing a welcome lift post-uncertainty. Investors view this as a stabilizing catalyst amid upcoming earnings and policy events. 💹 #trade #tariffs #marketrally"  
![@dg_fit61882 Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::1888599248654233600.png) [@dg_fit61882](/creator/x/dg_fit61882) on [X](/post/tweet/1949542875953586604) 2025-07-27 18:50:17 UTC XX followers, XX engagements


"12/12 If youre looking for asymmetric biotech setups low float FDA approval commercial launch catalyst and true unmet medical need $ITRM is one of the cleanest setups Ive ever seen. Im in heavy. DYOR. Not financial advice. #biotech #ITRM #stocks #investing"  
![@dg_fit61882 Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::1888599248654233600.png) [@dg_fit61882](/creator/x/dg_fit61882) on [X](/post/tweet/1948104198249414932) 2025-07-23 19:33:29 UTC XX followers, XXX engagements


"8/ 🔭 Catalysts Still Coming Even in a tough tape 2H 2025 brings big moments: $PMN Phase 1b readout $IXHL Phase X data next week $ABVX launching Phase X UC $VYGR tau program advancing $ACAD mid-stage psychosis data Eyes on timelines"  
![@dg_fit61882 Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::1888599248654233600.png) [@dg_fit61882](/creator/x/dg_fit61882) on [X](/post/tweet/1949291900651081865) 2025-07-27 02:12:59 UTC XX followers, XXX engagements


"$PASG just took a starter. Will wait for volume to come in for a larger allocation"  
![@dg_fit61882 Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::1888599248654233600.png) [@dg_fit61882](/creator/x/dg_fit61882) on [X](/post/tweet/1947671467648233589) 2025-07-22 14:53:58 UTC XX followers, XXX engagements


"5/12 Lets talk market size. Even if ORLYNVAH captures just X% of the U.S. uUTI market thats $250M/year in sales. There is zero oral penem competition. IV penems like ertapenem already generate $100M$500M/yr and they require hospitalization"  
![@dg_fit61882 Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::1888599248654233600.png) [@dg_fit61882](/creator/x/dg_fit61882) on [X](/post/tweet/1948104185066787259) 2025-07-23 19:33:26 UTC XX followers, XX engagements


"@PeloSwing Bought some long term $CMG XXXX calls"  
![@dg_fit61882 Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::1888599248654233600.png) [@dg_fit61882](/creator/x/dg_fit61882) on [X](/post/tweet/1949213695470715033) 2025-07-26 21:02:14 UTC XX followers, XX engagements


"9/ 🧵 XX Stocks to Watch Across the Sector Heres a mix of leaders innovators and speculative names: $LLY $RHHBY $CRSP $EDIT $BEAM $VYGR $ACAD $PMN $ABVX $IXHL $REGN $BIIB $MGNX $CELA $NVAX $SPRO $XOMA $GNFT $VRTX $ICON Tag your favorites"  
![@dg_fit61882 Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::1888599248654233600.png) [@dg_fit61882](/creator/x/dg_fit61882) on [X](/post/tweet/1949291903020589482) 2025-07-27 02:13:00 UTC XX followers, XXX engagements


"6/12 In June 2025 Iterum announced a full commercial partnership with EVERSANA one of the top commercial launch firms in pharma. U.S. launch is scheduled for Q4 2025. Everything is in motion. This is happening. No guessing"  
![@dg_fit61882 Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::1888599248654233600.png) [@dg_fit61882](/creator/x/dg_fit61882) on [X](/post/tweet/1948104186786369572) 2025-07-23 19:33:26 UTC XX followers, XXX engagements


"Bright Minds Biosciences ($DRUG) trades at $XXXXX giving it a market cap of $250M with just 7.08M shares outstanding (7375% institutional ownership) . Its lead molecule BMB101 is now in an open-label Phase X trial for absence epilepsy & DEE after XXX% seizure survival in SUDEP mouse models . TD Cowen and Chardan initiated Buy coverage with price targets in the $80$92 range . Highly selective 5HT2C agonist designed to minimize tolerance via Gq pathway activation. Phase X depends on upcoming data. #Biotech #Epilepsy #CNS #Microcap"  
![@dg_fit61882 Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::1888599248654233600.png) [@dg_fit61882](/creator/x/dg_fit61882) on [X](/post/tweet/1949182232171855923) 2025-07-26 18:57:12 UTC XX followers, XX engagements


"🚨 $SRPT update (7/16): XX% workforce cut (500 jobs) $400M in annual cost savings ELEVIDYS to carry FDA black box warning for liver injury Refocusing pipeline on high-impact siRNA programs Q2 revenue: $513M ($282M ELEVIDYS)"  
![@dg_fit61882 Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::1888599248654233600.png) [@dg_fit61882](/creator/x/dg_fit61882) on [X](/post/tweet/1945575205101085069) 2025-07-16 20:04:10 UTC XX followers, XXX engagements


"$PASG 3x average volume up 8%. Will look for continuation over $X for a full entry"  
![@dg_fit61882 Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::1888599248654233600.png) [@dg_fit61882](/creator/x/dg_fit61882) on [X](/post/tweet/1947748804859727916) 2025-07-22 20:01:17 UTC XX followers, XX engagements


"$DMAC is on deck for a pivotal readout: preliminary safety BP & placental flow data from Phase X Part 1A preeclampsia study are expected midJuly. With no approved treatments and $37M cash to Q3 2026 this could mark a breakthroughor highlight early safety/efficacy risks"  
![@dg_fit61882 Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::1888599248654233600.png) [@dg_fit61882](/creator/x/dg_fit61882) on [X](/post/tweet/1944471934521184484) 2025-07-13 19:00:10 UTC XX followers, XXX engagements


"1/12 🚨 $ITRM is one of my largest holdings. They just hit a key support level from pre-FDA approval and now have an FDA-approved drug a Q4 launch a $2B+ market and no U.S. competition. Let me walk you through why Im this bullish 🧵👇"  
![@dg_fit61882 Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::1888599248654233600.png) [@dg_fit61882](/creator/x/dg_fit61882) on [X](/post/tweet/1948104177756127377) 2025-07-23 19:33:24 UTC XX followers, XXX engagements